Patients With Chronic Lymphocytic Leukemia Belonging To The B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival After Chemo- Or Chemoimmunotherapy In The Hovon68 Trial
BLOOD(2017)
摘要
Introduction:
更多查看译文
关键词
chronic lymphocytic leukemia,chemoimmunotherapy,belonging progression free survival,b-cell
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要